Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

CDXC

Chromadex Corp

Sep 20 • 04:00PM ET

3.63

Dollar change -0.07
Percentage change -1.89	%

Consumer Defensive • Packaged Foods • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO IWC GSSC VTWG RSSL QQQS

Index	RUT	P/E	-	EPS (ttm)	-0.02	Insider Own	36.88%	Shs Outstand	74.98M	Perf Week	2.25%
Market Cap	275.63M	Forward P/E	43.24	EPS next Y	0.08	Insider Trans	-0.08%	Shs Float	47.93M	Perf Month	5.37%
Income	-1.35M	PEG	-	EPS next Q	0.01	Inst Own	21.99%	Short Float	6.51%	Perf Quarter	32.97%
Sales	85.58M	P/S	3.22	EPS this Y	120.57%	Inst Trans	-19.13%	Short Ratio	8.16	Perf Half Y	13.44%
Book/sh	0.41	P/B	8.92	EPS next Y	482.99%	ROA	-2.52%	Short Interest	3.12M	Perf Year	163.04%
Cash/sh	0.37	P/C	9.88	EPS next 5Y	-	ROE	-4.67%	52W Range	1.25 - 4.65	Perf YTD	153.85%
Dividend Est.	-	P/FCF	309.69	EPS past 5Y	35.83%	ROI	-4.11%	52W High	-21.94%	Beta	1.86
Dividend TTM	-	Quick Ratio	2.12	Sales past 5Y	22.27%	Gross Margin	60.82%	52W Low	190.40%	ATR (14)	0.22
Dividend Ex-Date	-	Current Ratio	2.76	EPS Y/Y TTM	79.61%	Oper. Margin	-0.00%	RSI (14)	61.01	Volatility	7.24% 6.30%
Employees	106	Debt/Eq	0.10	Sales Y/Y TTM	5.74%	Profit Margin	-1.58%	Recom	1.00	Target Price	6.92
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	99.32%	Payout	-	Rel Volume	1.66	Prev Close	3.70
Sales Surprise	-2.51%	EPS Surprise	100.00%	Sales Q/Q	11.89%	Earnings	Aug 07 AMC	Avg Volume	382.26K	Price	3.63
SMA20	6.53%	SMA50	15.49%	SMA200	38.14%	Trades		Volume	634,583	Change	-1.89%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-16-22	Downgrade	Oppenheimer	Outperform → Perform
Aug-11-22	Downgrade	B. Riley Securities	Buy → Neutral	$6 → $2.40
Mar-08-22	Initiated	ROTH Capital	Buy	$7
Oct-16-19	Initiated	Oppenheimer	Outperform	$6
Feb-14-19	Initiated	B. Riley FBR	Buy	$7
Nov-27-17	Resumed	H.C. Wainwright	Buy	$6 → $8
Sep-25-17	Initiated	Ladenburg Thalmann	Buy	$7
Jan-03-17	Initiated	Rodman & Renshaw	Buy	$6

Today 08:32AM	ChromaDex Appoints Ozan Pamir as Chief Financial Officer (Business Wire)
Sep-10-24 08:32AM	ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen IV and Injection Offerings to Additional Leading Wellness Clinics (Business Wire)
Sep-09-24 08:34AM	ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions (Business Wire)
Aug-23-24 08:34AM	ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024 (Business Wire) +6.69%
Aug-19-24 08:32AM	ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ (Business Wire)
06:25PM	Loading…
Aug-07-24 06:25PM	ChromaDex (CDXC) Reports Break-Even Earnings for Q2 (Zacks) -6.74% +9.51%
05:25PM	ChromaDex: Q2 Earnings Snapshot (Associated Press Finance)
04:04PM	ChromaDex Corporation Reports Second Quarter 2024 Financial Results (Business Wire)
Aug-05-24 08:32AM	ChromaDex to Present at Canaccord Genuitys 44th Annual Growth Conference (Business Wire)
Jul-24-24 08:34AM	ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 (Business Wire)
Jul-23-24 08:32AM	ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs) (Business Wire)
Jul-22-24 08:34AM	ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel (Business Wire) +7.03%
Jul-16-24 08:34AM	ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen Will Debut at Leading Wellness Clinics in August (Business Wire) +10.83%
Jul-01-24 08:32AM	ChromaDex to Join Russell 2000 Index (Business Wire)
Jun-24-24 08:32AM	Milestone Phase II Clinical Study Demonstrates Niagen, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD) (Business Wire) -6.59%
08:32AM	Loading…
Jun-13-24 08:32AM	ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen (Patented Nicotinamide Riboside Chloride or NRC) (Business Wire) +5.61%
Jun-10-24 09:45AM	ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag (Zacks)
Jun-07-24 08:34AM	ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT) (Business Wire) +11.89%
Jun-04-24 08:32AM	ChromaDex to Participate in Renmarks Virtual Non-Deal Roadshow on Tuesday, June 11, 2024 (Business Wire)
May-23-24 08:34AM	ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 (Business Wire)
May-22-24 08:32AM	ChromaDexs Niagen Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award (Business Wire)
May-10-24 03:22PM	ChromaDex Corp (CDXC) Q1 2024 Earnings: Aligns with EPS Projections, Misses Revenue Estimates (GuruFocus.com)
May-09-24 02:34PM	ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript (Insider Monkey) -8.09%
07:17AM	Q1 2024 Chromadex Corp Earnings Call (Thomson Reuters StreetEvents)
03:42AM	ChromaDex Corp (CDXC) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-08-24 08:58PM	CDXC Stock Earnings: ChromaDex Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:04PM	ChromaDex: Q1 Earnings Snapshot (Associated Press Finance)
04:04PM	ChromaDex Corporation Reports First Quarter 2024 Financial Results (Business Wire)
Apr-30-24 08:32AM	ChromaDex's NIAGEN (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar Cellular Nutrition Cellular Energy Supplement (Business Wire)
Apr-25-24 08:34AM	ChromaDex Announces Nationwide Launch of Tru Niagen at The Vitamin Shoppe (Business Wire)
08:34AM	Loading…
Apr-24-24 08:34AM	ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (Business Wire)
Apr-23-24 08:32AM	ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen at Sprouts Farmers Market (Business Wire) +15.25%
Mar-26-24 08:32AM	ChromaDex Announces Tru Niagen is Now Third-Party Verified Through the Alkemist Assured Transparency Program (Business Wire)
Mar-07-24 01:59PM	ChromaDex Corp (CDXC) Reports Encouraging Fiscal Year 2023 Results with Positive Adjusted EBITDA (GuruFocus.com) -8.05%
10:37AM	ChromaDex Corporation (NASDAQ:CDXC) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:27AM	Q4 2023 Chromadex Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-06-24 09:53PM	CDXC Stock Earnings: ChromaDex Beats Revenue for Q4 2023 (InvestorPlace)
04:04PM	ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results (Business Wire)
Feb-21-24 08:32AM	ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024 (Business Wire)
Feb-05-24 08:32AM	ChromaDex to Participate in Renmarks Virtual Non-Deal Roadshow on Monday, February 12, 2024 (Business Wire)
Jan-26-24 04:08PM	ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference (Business Wire)
Dec-20-23 09:04AM	ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen (Business Wire)
Dec-12-23 10:30AM	Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+ (PR Newswire)
Nov-30-23 08:34AM	A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD) (Business Wire)
Nov-15-23 08:32AM	Newly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen, Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) Patients (Business Wire) +9.49%
Nov-10-23 12:54PM	ChromaDex Corporation (NASDAQ:CDXC) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:32AM	ChromaDex to Participate in Renmarks Virtual Non-Deal Roadshow on Tuesday, November 14, 2023 (Business Wire) -11.25%
Nov-08-23 06:33PM	ChromaDex Corp (CDXC) Reports Growth in Net Sales and Positive Adjusted EBITDA in Q3 2023 (GuruFocus.com)
04:48PM	ChromaDex: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	ChromaDex Corporation Reports Third Quarter 2023 Financial Results (Business Wire)
Nov-01-23 08:34AM	ChromaDex Debuts Clinical Strength Tru Niagen Pro 1,000mg Featuring Niagen (Patented Nicotinamide Riboside), One of the Most Efficient Nicotinamide Adenine Dinucleotide (NAD+) Boosters Available, to Consumers Nationwide (Business Wire)
Oct-31-23 08:34AM	ChromaDex to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 (Business Wire)
Oct-26-23 08:32AM	ChromaDex and Zesty Paws Crack the Code on Cellular Health for Dogs With Healthy Aging Line (Business Wire)
Oct-02-23 08:32AM	A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients (Business Wire)
Aug-24-23 08:32AM	Preclinical Study Builds on Growing Body of Evidence Showcasing Exogenous Nicotinamide Mononucleotide (NMN) Must be Converted to Nicotinamide Riboside (NR), Making NR a More Efficient Nicotinamide Adenine Dinucleotide (NAD+) Precursor to NMN (Business Wire)
Aug-12-23 09:04AM	Analysts Expect Breakeven For ChromaDex Corporation (NASDAQ:CDXC) Before Long (Simply Wall St.)
Aug-10-23 10:38AM	Q2 2023 Chromadex Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-09-23 05:40PM	ChromaDex (CDXC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:37PM	ChromaDex: Q2 Earnings Snapshot (Associated Press Finance)
04:02PM	ChromaDex Corporation Reports Second Quarter 2023 Financial Results (Business Wire)
Aug-08-23 08:34AM	ChromaDex Launches Tru Niagen® with iHerb, the Worlds Number One Online Destination for Health and Wellness (Business Wire)
Aug-07-23 08:32AM	ChromaDex to Participate in Renmarks Virtual Non-Deal Roadshow Series (Business Wire)
Aug-02-23 08:02AM	ChromaDex to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023 (Business Wire)
Jul-18-23 08:32AM	Findings from Published Abstracts Showcase the Importance of Nicotinamide Adenine Dinucleotide (NAD+) in Glaucoma Patients and that Supplementation with Nicotinamide Riboside (NR) Demonstrate Promising Effects (Business Wire)
Jun-16-23 08:32AM	ChromaDex, a Global Authority on Nicotinamide Adenine Dinucleotide (NAD+), Celebrates the 10th Anniversary of its ChromaDex External Research Program (CERP), the Industry Leading Research Program Advancing the Science of NAD+ and Healthy Aging (Business Wire)
Jun-08-23 08:19AM	It's A Story Of Risk Vs Reward With ChromaDex Corporation (NASDAQ:CDXC) (Simply Wall St.)
May-30-23 08:34AM	ChromaDex to Participate in the LD Micro Invitational XIII (Business Wire)
May-11-23 08:34AM	ChromaDex to Present at the Lytham Partners Spring 2023 Investor Conference (Business Wire)
May-10-23 05:35PM	ChromaDex (CDXC) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.14%
04:32PM	ChromaDex: Q1 Earnings Snapshot (AP Finance)
04:02PM	ChromaDex Corporation Reports First Quarter 2023 Financial Results (Business Wire)
May-02-23 08:32AM	ChromaDex to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023 (Business Wire)
06:31AM	We Think ChromaDex (NASDAQ:CDXC) Can Afford To Drive Business Growth (Simply Wall St.)
Apr-12-23 01:04PM	Individual investors account for 44% of ChromaDex Corporation's (NASDAQ:CDXC) ownership, while insiders account for 26% (Simply Wall St.)
Mar-27-23 06:43AM	Bullish ChromaDex Corporation (NASDAQ:CDXC) insiders filled their treasuries with US$1.6m worth of stock over last year (Simply Wall St.)
Mar-10-23 05:23AM	ChromaDex Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.) -9.76%
02:28AM	ChromaDex Corporation (NASDAQ:CDXC) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-09-23 09:06AM	Q4 2022 Chromadex Corp Earnings Call (Thomson Reuters StreetEvents) -10.38%
Mar-08-23 06:25PM	ChromaDex (CDXC) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +12.96%
04:02PM	ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2022 Results (Business Wire)
Mar-06-23 08:34AM	ChromaDex to Participate at the 35th Annual ROTH Capital Partners Conference on March 13, 2023 (Business Wire)
Mar-02-23 10:00AM	ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: Should You Buy? (Zacks)
Mar-01-23 10:00AM	Will ChromaDex (CDXC) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-27-23 08:32AM	ChromaDex to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Wednesday, March 8, 2023 (Business Wire) +5.56%
Feb-22-23 08:34AM	ChromaDex Announces Issuance of New U.S. Patent on Dihydronicotinamide Riboside (NRH) and Dihydronicotinic Acid Riboside (NARH), Further Solidifying ChromaDex as the Leader in the Nicotinamide Adenine Dinucleotide (NAD+) Precursor Space (Business Wire)
Feb-21-23 08:32AM	A Letter from the ChromaDex Chief Executive Officer (Business Wire) -5.49%
Jan-31-23 08:32AM	ChromaDex Shares Promising Findings from a Clinical Study Showcasing Combined Metabolic Activators (CMAs), Featuring Nicotinamide Riboside (NR), Improved Cognitive Functions in Alzheimer's Disease (AD) Patients (Business Wire)
Jan-17-23 08:28AM	ChromaDex Shares Promising Findings from First-Of-Its Kind Clinical Study to Demonstrate Oral Nicotinamide Riboside (NR) Supplementation Increases Muscle Mitochondrial Biogenesis (Business Wire)
Jan-15-23 08:52AM	Strong week for ChromaDex (NASDAQ:CDXC) shareholders doesn't alleviate pain of five-year loss (Simply Wall St.)
Jan-12-23 08:34AM	ChromaDex Appoints Leading Aging and Neurodegenerative Disease Researcher, Dr. Vilhelm Bohr, to its Scientific Advisory Board (SAB) (Business Wire)
Jan-05-23 08:33AM	ChromaDex Named Brianna Gerber Chief Financial Officer (Business Wire) +5.14%
Dec-27-22 08:30AM	ChromaDex Shares Promising Findings from Clinical Study Demonstrating Oral Supplementation with Nicotinamide Riboside (NR) Increased Nicotinamide Adenine Dinucleotide (NAD+) Levels in the Brain and Positively Impacted Neurodegenerative Biomarkers (Business Wire)
Dec-19-22 09:35AM	Down 9.6% in 4 Weeks, Here's Why ChromaDex (CDXC) Looks Ripe for a Turnaround (Zacks)
Dec-16-22 09:35AM	Here's Why ChromaDex (CDXC) is Poised for a Turnaround After Losing 7.5% in 4 Weeks (Zacks) -6.25%
Nov-11-22 08:12AM	ChromaDex Reports FDAs Conclusion that Nicotinamide Mononucleotide (NMN) May Not Be Sold or Marketed as a Dietary Supplement in the United States (Business Wire)
Nov-09-22 05:02AM	Zacks.com featured highlights Oxford Industries, ChromaDex, UserTesting and TravelCenters of America (Zacks)
Nov-02-22 05:35PM	ChromaDex (CDXC) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:02PM	ChromaDex Corporation Reports Third Quarter 2022 Financial Results (Business Wire)
11:40AM	ChromaDex Corporation's (NASDAQ:CDXC) market cap rose US$16m last week; individual investors who hold 36% profited and so did insiders (Simply Wall St.)
Oct-26-22 08:35AM	ChromaDex to Report Third Quarter Financial Results on Wednesday, November 2, 2022 (Business Wire)

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company's patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm's proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Patrick Kristin	Director	Aug 23 '24	Option Exercise	1.67	23,000	38,320	23,000	Aug 26 07:06 PM
Patrick Kristin	Director	Aug 23 '24	Sale	3.57	23,000	82,110	0	Aug 26 07:06 PM
Kristin Patrick	affiliate	Aug 23 '24	Proposed Sale	3.69	23,000	84,810		Aug 23 11:52 AM
Gerber Brianna	Chief Financial Officer	Dec 01 '23	Buy	1.41	5,000	7,050	27,436	Dec 04 04:12 PM

Open in Screener

CELH

Celsius Holdings Inc

Sep 20 • 04:00PM ET

33.17

Dollar change -0.90
Percentage change -2.64	%

Consumer Defensive • Beverages - Non-Alcoholic • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

CELH Celsius Holdings Inc daily Stock Chart

Held by: VTI IJH VB VBK VXF XMHQ MDY IJK IWP IWF

Index	-	P/E	32.51	EPS (ttm)	1.02	Insider Own	28.67%	Shs Outstand	231.79M	Perf Week	-1.54%
Market Cap	7.73B	Forward P/E	31.89	EPS next Y	1.04	Insider Trans	-12.72%	Shs Float	166.24M	Perf Month	-19.65%
Income	241.12M	PEG	1.99	EPS next Q	0.10	Inst Own	69.32%	Short Float	13.27%	Perf Quarter	-46.91%
Sales	1.49B	P/S	5.19	EPS this Y	7.94%	Inst Trans	-0.01%	Short Ratio	3.79	Perf Half Y	-63.53%
Book/sh	1.78	P/B	18.62	EPS next Y	25.16%	ROA	18.71%	Short Interest	22.06M	Perf Year	-45.15%
Cash/sh	3.88	P/C	8.56	EPS next 5Y	16.30%	ROE	26.57%	52W Range	31.55 - 99.62	Perf YTD	-39.16%
Dividend Est.	-	P/FCF	31.43	EPS past 5Y	-	ROI	19.43%	52W High	-66.70%	Beta	1.84
Dividend TTM	-	Quick Ratio	3.80	Sales past 5Y	93.37%	Gross Margin	50.19%	52W Low	5.13%	ATR (14)	2.00
Dividend Ex-Date	-	Current Ratio	4.38	EPS Y/Y TTM	268.47%	Oper. Margin	22.42%	RSI (14)	35.76	Volatility	5.37% 5.33%
Employees	765	Debt/Eq	0.00	Sales Y/Y TTM	56.50%	Profit Margin	16.18%	Recom	1.56	Target Price	50.36
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	62.90%	Payout	0.00%	Rel Volume	1.25	Prev Close	34.07
Sales Surprise	2.79%	EPS Surprise	20.59%	Sales Q/Q	23.35%	Earnings	Aug 06 BMO	Avg Volume	5.82M	Price	33.17
SMA20	-6.23%	SMA50	-19.70%	SMA200	-46.44%	Trades		Volume	7,268,132	Change	-2.64%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-05-24	Reiterated	ROTH MKM	Buy	$65 → $45
Aug-08-24	Downgrade	BofA Securities	Neutral → Underperform	$60 → $32
Aug-07-24	Reiterated	Maxim Group	Buy	$90 → $65
Jul-15-24	Reiterated	TD Cowen	Buy	$85 → $68
Jun-25-24	Initiated	Truist	Hold	$60
Jun-24-24	Initiated	Exane BNP Paribas	Outperform	$87
Jun-18-24	Reiterated	Maxim Group	Buy	$110 → $90
Jun-17-24	Reiterated	ROTH MKM	Buy	$96 → $87
Apr-01-24	Reiterated	Maxim Group	Buy	$100 → $110
Mar-04-24	Reiterated	Wedbush	Outperform	$75 → $90
Mar-01-24	Reiterated	Maxim Group	Buy	$65 → $100
Feb-02-24	Upgrade	Maxim Group	Hold → Buy	$65
Jan-19-24	Downgrade	BofA Securities	Buy → Neutral	$65
Nov-13-23	Initiated	Jefferies	Buy	$217
Oct-31-23	Initiated	Morgan Stanley	Equal-Weight	$190
Oct-23-23	Initiated	William Blair	Outperform
Sep-15-23	Initiated	TD Cowen	Outperform	$250
Aug-09-23	Reiterated	Wedbush	Outperform	$155 → $180
Jul-19-23	Downgrade	Maxim Group	Buy → Hold
Jun-23-23	Initiated	Stephens	Overweight	$180

Show Previous Ratings

Today 09:30AM	Wall Street Bulls Look Optimistic About Celsius (CELH): Should You Buy? (Zacks)
05:18AM	3 Growth Stocks Down 35% to 65% to Buy Right Now (Motley Fool)
Sep-19-24 09:07PM	Lightning Round: Something is wrong with Celsius Holdings, says Jim Cramer (CNBC TV)
04:15PM	Celsius Holdings Appoints Hans Melotte to the Companys Board of Directors (Business Wire)
07:39AM	Best Stock to Buy Right Now: Celsius Holdings vs. Monster Beverage (Motley Fool)
05:45PM	Loading…
Sep-18-24 05:45PM	Celsius Holdings Inc. (CELH) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
09:30AM	Celsius Holdings: Buy, Sell, or Hold? (Motley Fool)
05:20AM	1 Growth Stock Down 65% to Buy Right Now (Motley Fool)
Sep-17-24 12:38PM	Celsius Holdings, Inc. (CELH): A Bull Case Theory (Insider Monkey)
04:08AM	Beverages and Alcohol Stocks Q2 Highlights: Anheuser-Busch (NYSE:BUD) (StockStory)
Sep-16-24 06:53AM	Jim Cramer on Celsius Holdings Inc. (CELH): I Dont Trust It (Insider Monkey)
Sep-15-24 10:56AM	Jim Cramer Weighs in on Celsius Holdings (CELH): Confusion Amidst Sales Shortfall (Insider Monkey)
Sep-13-24 03:30AM	2 Stocks That Could Create Lasting Generational Wealth (Motley Fool)
03:13AM	Unpacking Q4 Earnings: Brown-Forman (NYSE:BF.B) In The Context Of Other Beverages and Alcohol Stocks (StockStory)
Sep-12-24 01:22AM	FMR LLC Reduces Stake in Celsius Holdings Inc (GuruFocus.com)
05:45PM	Loading…
Sep-11-24 05:45PM	Celsius Holdings Inc. (CELH) Outperforms Broader Market: What You Need to Know (Zacks)
09:00AM	Celsius Holdings Inc. (CELH) is Attracting Investor Attention: Here is What You Should Know (Zacks)
03:36AM	Q4 Rundown: Brown-Forman (NYSE:BF.B) Vs Other Beverages and Alcohol Stocks (StockStory)
Sep-10-24 05:37AM	Better Buy: Celsius Stock at a 52-Week Low or a 50/50 Split of Dividend Kings Pepsi and Coca-Cola? (Motley Fool)
Sep-09-24 08:37PM	Is Celsius Stock The Next Coca-Cola? (Motley Fool)
08:19PM	1 Growth Stock Down 66% to Buy Right Now (Motley Fool)
06:19PM	Why Celsius Holdings Stock Lost 19% in August (Motley Fool)
09:10AM	This Ultimate Growth Stock Is Down 66%: Time to Buy the Dip? (Motley Fool)
03:42AM	Unpacking Q2 Earnings: Coca-Cola (NYSE:KO) In The Context Of Other Beverages and Alcohol Stocks (StockStory)
Sep-08-24 05:02AM	2 Nasdaq Stocks to Buy Before They Soar as Much as 141%, According to Select Wall Street Analysts (Motley Fool)
Sep-07-24 05:14AM	Celsius Holdings (CELH): A Look at Its Position Among Top Buy-the-Dip Stocks (Insider Monkey)
Sep-05-24 02:19PM	Why Celsius Stock Plummeted This Week (Motley Fool)
11:55AM	When Will Celsius Stock Catch a Break in 2024? (Motley Fool)
01:30AM	This Energy Drink Is Everywhere. Its Stock Can Still Provide a Jolt. (Barrons.com)
Sep-04-24 03:27PM	Why Celsius Stock Suddenly Plunged Today (Motley Fool) -11.60%
02:25PM	Loading…
02:25PM	7 Best Buy-the-Dip Stocks to Invest In (Insider Monkey)
09:30AM	Wall Street Analysts Think Celsius (CELH) Is a Good Investment: Is It? (Zacks)
Aug-31-24 06:24PM	Forget Celsius Holdings: This Stock Has Made Far More Millionaires (Motley Fool)
Aug-30-24 10:00AM	3 Reasons Celsius Holdings' Growth Rate Could Improve (and 1 Reason Why It May Slow Down) (Motley Fool)
Aug-28-24 04:30PM	Celsius Holdings to Participate in Upcoming Investor Conferences (Business Wire)
09:00AM	Celsius Holdings Inc. (CELH) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Aug-27-24 05:20AM	4 Reasons to Buy Celsius Stock Like There's No Tomorrow (Motley Fool)
Aug-25-24 11:39AM	Where Will Celsius Stock Be in 3 Years? (Motley Fool)
09:53AM	Down Nearly 60% From Its High, Is Celsius Holdings Stock a Bargain Buy? (Motley Fool)
Aug-21-24 07:00AM	Don't Panic in This Stock Market Sell-Off: Buy These 2 Stocks Instead (Motley Fool)
04:20AM	Celsius Holdings (CELH) Declined as Revenues Fell Short of Estimates (Insider Monkey)
Aug-20-24 07:46AM	Celsius Holdings (CELH) Lagged Due to Market Slow Down (Insider Monkey)
Aug-19-24 11:55AM	3 Reasons I Own Celsius and Not Monster Stock (Motley Fool)
09:30AM	Celsius (CELH) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
04:20AM	Unpacking Q4 Earnings: Brown-Forman (NYSE:BF.B) In The Context Of Other Beverages and Alcohol Stocks (StockStory)
Aug-18-24 05:20AM	2 Growth Stocks Down Over 60% to Buy Right Now (Motley Fool)
Aug-15-24 09:00AM	Investors Heavily Search Celsius Holdings Inc. (CELH): Here is What You Need to Know (Zacks) +6.02%
06:40AM	7 Meme Stocks to Buy on the Dip: August 2024 (InvestorPlace)
Aug-14-24 10:11AM	Celsius Holdings: Buy, Sell, or Hold? (Motley Fool)
07:33AM	Why is there a slowdown in US energy drinks? (Just Drinks)
06:00AM	Stress on Shelvesthe Battle for Space in Store Aisles (The Wall Street Journal)
Aug-13-24 11:50AM	3 Growth Stocks That Could Skyrocket in 2024 and Beyond (Motley Fool)
10:12AM	Celsius Holdings (CELH) Trading Near 52-Week Low: How to Play Ahead? (Zacks)
05:00AM	You cant replicate a Celsius: How the energy drink maker evolved from an unknown to category giant (Food Dive)
01:59AM	Down 62% from Highs, Is Celsius Stock (NASDAQ:CELH) a Buy? (TipRanks)
Aug-12-24 08:00PM	Is It Too Late to Buy Celsius Stock? (Motley Fool)
09:15AM	International Markets and Celsius (CELH): A Deep Dive for Investors (Zacks)
07:51AM	Best Stock to Buy Right Now: Monster Beverage vs. Celsius Holdings (Motley Fool)
Aug-11-24 11:38AM	1 Growth Stock Down 56% to Buy Right Now (Motley Fool)
Aug-10-24 07:35AM	International Sales Energize Celsius. Is It Time to Buy the Beaten-Down Stock? (Motley Fool)
Aug-07-24 12:19PM	Analyst Report: Celsius Holdings, Inc. (Morningstar Research)
12:44AM	Q2 2024 Celsius Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-06-24 04:25PM	Celsius Stock Reverses After Record Quarter; Molson Coors Brews Up Beat (Investor's Business Daily)
12:34PM	Celsius Holdings reports growth amidst energy category slowdown (Just Drinks)
10:34AM	Stocks to Watch Tuesday: Uber, Caterpillar, Palantir, Lucid (The Wall Street Journal)
10:24AM	Celsius Stock Pops On Record Quarter; Molson Coors Brews Up Beat (Investor's Business Daily)
10:14AM	Hims & Hers Health, FuboTV, Celsius: 3 Stock in Focus (Yahoo Finance Video)
09:30AM	Celsius (CELH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:10AM	Celsius Holdings Inc. (CELH) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:08AM	Celsius (NASDAQ:CELH) Posts Better-Than-Expected Sales In Q2, Stock Jumps 10.4% (StockStory)
06:00AM	Celsius Holdings Reports Second Quarter 2024 Financial Results (Business Wire)
Aug-05-24 09:32AM	Celsius Holdings (CELH) Before Q2 Earnings: To Buy or Not to Buy? (Zacks)
03:09AM	Celsius (CELH) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Aug-03-24 04:00PM	This Growth Stock Is Down 52%: Is It a No-Brainer Buy Right Now? (Motley Fool)
10:15AM	2 Unstoppable Growth Stocks to Buy on the Dip (Motley Fool)
Aug-02-24 06:22PM	Analyst Report: Celsius Holdings, Inc. (Morningstar Research)
09:00AM	Here is What to Know Beyond Why Celsius Holdings Inc. (CELH) is a Trending Stock (Zacks)
Aug-01-24 09:30AM	Wall Street Analysts See Celsius (CELH) as a Buy: Should You Invest? (Zacks)
Jul-31-24 05:45PM	Celsius Holdings Inc. (CELH) Exceeds Market Returns: Some Facts to Consider (Zacks)
Jul-30-24 08:45AM	Celsius Holdings Stock Is Down 52% From Its 52-Week High. Time to Buy? (Motley Fool)
08:00AM	Celsius Holdings to Release Second Quarter Results on Tuesday, Aug. 6, 2024 (Business Wire)
Jul-25-24 05:45PM	Celsius Holdings Inc. (CELH) Rises As Market Takes a Dip: Key Facts (Zacks)
11:55AM	1 Growth Stock Down 54% to Buy Right Now (Motley Fool)
06:06AM	3 Oversold Stocks to Buy on the Dip: July 2024 (InvestorPlace)
Jul-24-24 01:32PM	7 Bargain Stocks That Can Return 50% in a Year (InvestorPlace)
Jul-23-24 07:28AM	Meet the CFO-turned-CEO driving record growth for cult-favorite energy drink Celsius (Fortune)
Jul-21-24 08:30AM	7 Growth Stocks to Buy With $1,000 or Youll Be Kicking Yourself in 2025 (InvestorPlace)
Jul-20-24 06:30PM	2 Growth Stocks That Could Skyrocket in the Back Half of 2024 and Beyond (Motley Fool)
11:00AM	Celsius Stock Is Beaten Down Now, but It Could Still Soar (Motley Fool)
Jul-19-24 03:24PM	Why Celsius Holdings Stock Slipped (Again) This Week (Motley Fool)
Jul-18-24 05:45PM	Celsius Holdings Inc. (CELH) Rises As Market Takes a Dip: Key Facts (Zacks)
11:55AM	When Will Celsius Stock Finally Hit Rock Bottom? (Motley Fool)
07:44AM	3 Russell 2000 Stocks to Buy Now: Q3 Edition (InvestorPlace)
04:11AM	Celsius Stock Has Plunged Nearly 50% From 2024 Highs. Here's What Happened to Monster Beverage Stock When the Same Thing Happened in 2012. (Motley Fool)
Jul-16-24 09:30AM	Should You Invest in Celsius (CELH) Based on Bullish Wall Street Views? (Zacks)
07:28AM	Bank of America, Morgan Stanley earnings, June retail sales data: Yahoo Finance (Yahoo Finance Video)
05:53AM	Should You Believe in the Upside Potential of Celsius Holdings (CELH)? (Insider Monkey)
04:54AM	The Ultimate Growth Stock Is in a 45% Drawdown: Should You Buy the Dip for the Second Half of 2024? (Motley Fool)
Jul-15-24 03:30PM	How the Celsius CEO turned a cult-favorite energy drink into a stock-market lightning rod with 6,000% growth (Fortune) -10.65%
01:47PM	Dow notches record high amid political turmoil: Yahoo Finance (Yahoo Finance Video)

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fieldly John	Chief Executive Officer	Sep 13 '24	Option Exercise	1.71	1,297,827	2,216,806	1,887,337	Sep 16 06:31 PM
Fieldly John	Chief Executive Officer	Sep 12 '24	Option Exercise	1.97	192,318	378,671	589,510	Sep 16 06:31 PM
Fieldly John	Chief Executive Officer	Sep 13 '24	Sale	34.36	551,421	18,946,826	1,261,069	Sep 16 06:31 PM
Fieldly John	Chief Executive Officer	Sep 12 '24	Sale	32.80	74,847	2,454,982	1,812,490	Sep 16 06:31 PM
Fieldly John	Officer	Sep 13 '24	Proposed Sale	34.21	551,421	18,862,428		Sep 13 04:19 PM
Fieldly John	Officer	Sep 12 '24	Proposed Sale	32.80	74,847	2,455,268		Sep 12 03:50 PM
Milmoe William H.	10% Owner	Aug 22 '24	Option Exercise	1.08	30,000	32,400	326,245	Aug 26 05:00 PM
Milmoe William H.	10% Owner	Jun 11 '24	Option Exercise	1.08	43,000	46,440	269,245	Jun 13 05:43 PM
Milmoe William H.	10% Owner	Jun 12 '24	Option Exercise	1.08	27,000	29,160	296,245	Jun 13 05:43 PM
DeSantis Dean	10% Owner	May 16 '24	Sale	92.81	53,880	5,000,603	165,377	May 22 04:15 PM
Milmoe William H.	10% Owner	May 16 '24	Option Exercise	1.08	65,000	70,200	266,245	May 20 07:04 PM
Milmoe William H.	10% Owner	May 17 '24	Sale	92.95	40,000	3,718,000	226,245	May 20 07:04 PM
DeSantis Dean	10% Owner	May 07 '24	Sale	59.67	428,574	25,571,596	23,321,589	May 16 04:10 PM
DeSantis Dean	10% Owner	May 06 '24	Sale	59.67	428,574	25,571,596	23,750,163	May 16 04:10 PM
DeSantis Dean	10% Owner	May 03 '24	Sale	59.67	428,574	25,571,596	23,964,450	May 16 04:10 PM
DeSantis Dean	10% Owner	May 02 '24	Sale	59.67	428,574	25,571,596	24,178,737	May 16 04:10 PM
DeSantis Dean	10% Owner	May 01 '24	Sale	59.67	428,568	25,571,238	25,035,885	May 16 04:10 PM
DeSantis Dean	10% Owner	Apr 30 '24	Sale	59.67	428,568	25,571,238	25,250,169	May 16 04:10 PM
DeSantis Dean	10% Owner	Apr 29 '24	Sale	59.67	428,568	25,571,238	25,464,453	May 16 04:10 PM
DeSantis Deborah	10% Owner	May 07 '24	Sale	59.67	428,574	25,571,596	23,321,589	May 16 04:05 PM
DeSantis Deborah	10% Owner	May 01 '24	Sale	59.67	428,568	25,571,238	25,035,885	May 16 04:05 PM
DeSantis Deborah	10% Owner	Apr 30 '24	Sale	59.67	428,568	25,571,238	25,250,169	May 16 04:05 PM
DeSantis Deborah	10% Owner	Apr 29 '24	Sale	59.67	428,568	25,571,238	25,464,453	May 16 04:05 PM
DeSantis Deborah	10% Owner	May 06 '24	Sale	59.67	428,574	25,571,596	23,750,163	May 16 04:05 PM
DeSantis Deborah	10% Owner	May 03 '24	Sale	59.67	428,574	25,571,596	23,964,450	May 16 04:05 PM
DeSantis Deborah	10% Owner	May 02 '24	Sale	59.67	428,574	25,571,596	24,178,737	May 16 04:05 PM
Kravitz Hal	Director	May 14 '24	Sale	90.27	16,500	1,489,455	201,282	May 15 04:22 PM
Storey Paul H.	Chief Supply Chain Officer	May 07 '24	Sale	75.43	1,833	138,263	41,044	May 09 04:18 PM
Milmoe William H.	10% Owner	May 07 '24	Sale	59.67	428,574	25,571,596	23,321,589	May 07 05:00 PM
Milmoe William H.	10% Owner	May 06 '24	Sale	59.67	428,574	25,571,596	23,750,163	May 06 02:20 PM
Milmoe William H.	10% Owner	May 03 '24	Sale	59.67	428,574	25,571,596	23,964,450	May 06 02:20 PM
Milmoe William H.	10% Owner	May 02 '24	Sale	59.67	428,574	25,571,596	24,178,737	May 06 02:20 PM
Milmoe William H.	10% Owner	May 01 '24	Sale	59.67	428,568	25,571,238	25,035,885	May 01 05:16 PM
Milmoe William H.	10% Owner	Apr 30 '24	Sale	59.67	428,568	25,571,238	25,250,169	May 01 05:16 PM
Milmoe William H.	10% Owner	Apr 29 '24	Sale	59.67	428,568	25,571,238	25,464,453	May 01 05:16 PM
Langhans Jarrod	Chief Financial Officer	Apr 19 '24	Sale	69.42	4,079	283,164	83,670	Apr 19 04:38 PM
DeSantis Dean	10% Owner	Mar 13 '24	Sale	95.75	100,000	9,575,350	219,257	Mar 15 08:30 AM
Watson Kyle Audrey	Chief Marketing Officer	Mar 12 '24	Option Exercise	1.08	40,000	43,200	115,060	Mar 14 04:50 PM
Watson Kyle Audrey	Chief Marketing Officer	Mar 12 '24	Sale	89.17	40,000	3,566,800	75,060	Mar 14 04:50 PM
Levy Caroline S	Director	Mar 13 '24	Option Exercise	4.84	20,000	96,800	57,891	Mar 14 04:48 PM
Levy Caroline S	Director	Mar 13 '24	Sale	94.77	20,000	1,895,400	37,891	Mar 14 04:48 PM
Castaldo Nicholas	Director	Mar 04 '24	Option Exercise	1.08	165,000	178,200	517,864	Mar 05 06:06 PM
Castaldo Nicholas	Director	Mar 04 '24	Sale	83.33	165,000	13,749,450	352,864	Mar 05 06:06 PM
Ruberti Alexandre	Director	Mar 04 '24	Sale	83.17	23,000	1,912,910	25,991	Mar 05 06:04 PM
MILLER CHERYL	Director	Mar 04 '24	Sale	83.66	3,000	250,980	16,741	Mar 05 06:03 PM
Storey Paul H.	Chief Supply Chain Officer	Mar 04 '24	Sale	79.75	10,000	797,500	42,877	Mar 05 05:54 PM
Guilfoyle Tony	Chief Commercial Officer	Mar 04 '24	Sale	79.75	24,357	1,942,471	81,794	Mar 05 05:53 PM
Langhans Jarrod	Chief Financial Officer	Mar 04 '24	Sale	85.61	5,500	470,855	87,749	Mar 05 05:52 PM
Fieldly John	Chief Executive Officer	Mar 04 '24	Sale	85.07	119,604	10,174,712	380,244	Mar 05 05:50 PM
DeSantis Dean	10% Owner	Mar 04 '24	Sale	67.46	4,000,000	269,824,000	26,321,589	Mar 05 04:15 PM
DeSantis Deborah	10% Owner	Mar 04 '24	Sale	67.46	4,000,000	269,824,000	26,321,589	Mar 05 04:15 PM
Milmoe William H.	10% Owner	Mar 04 '24	Sale	67.46	4,000,000	269,824,000	26,321,589	Mar 05 04:15 PM
Milmoe William H.	10% Owner	Feb 29 '24	Sale	77.00	44,000	3,388,000	201,245	Mar 04 04:05 PM
DeSantis Deborah	10% Owner	Feb 01 '24	Sale	42.81	127,802	5,471,633	30,388,652	Feb 05 04:05 PM
DeSantis Deborah	10% Owner	Feb 02 '24	Sale	50.28	67,063	3,371,619	30,321,589	Feb 05 04:05 PM
Milmoe William H.	10% Owner	Feb 01 '24	Sale	42.81	127,802	5,471,633	30,388,652	Feb 05 04:05 PM
Milmoe William H.	10% Owner	Feb 02 '24	Sale	50.28	67,063	3,371,619	30,321,589	Feb 05 04:05 PM
DeSantis Dean	10% Owner	Feb 01 '24	Sale	42.81	127,802	5,471,633	30,388,652	Feb 05 04:05 PM
DeSantis Dean	10% Owner	Feb 02 '24	Sale	50.28	67,063	3,371,619	30,321,589	Feb 05 04:05 PM
DeSantis Deborah	10% Owner	Jan 29 '24	Sale	44.02	128,339	5,650,114	30,711,936	Jan 31 04:05 PM
DeSantis Deborah	10% Owner	Jan 30 '24	Sale	43.48	128,103	5,570,450	30,840,275	Jan 31 04:05 PM
DeSantis Deborah	10% Owner	Jan 31 '24	Sale	42.90	127,838	5,483,856	30,576,919	Jan 31 04:05 PM
Milmoe William H.	10% Owner	Jan 29 '24	Sale	44.02	128,339	5,650,114	30,711,936	Jan 31 04:05 PM
Milmoe William H.	10% Owner	Jan 30 '24	Sale	43.48	128,103	5,570,450	30,840,275	Jan 31 04:05 PM
Milmoe William H.	10% Owner	Jan 31 '24	Sale	42.90	127,838	5,483,856	30,576,919	Jan 31 04:05 PM
DeSantis Dean	10% Owner	Jan 29 '24	Sale	44.02	128,339	5,650,114	30,711,936	Jan 31 04:05 PM
DeSantis Dean	10% Owner	Jan 30 '24	Sale	43.48	128,103	5,570,450	30,840,275	Jan 31 04:05 PM
DeSantis Dean	10% Owner	Jan 31 '24	Sale	42.90	127,838	5,483,856	30,576,919	Jan 31 04:05 PM
DeSantis Deborah	10% Owner	Jan 24 '24	Sale	43.96	128,309	5,639,952	31,096,560	Jan 26 04:05 PM
DeSantis Deborah	10% Owner	Jan 25 '24	Sale	43.64	128,171	5,593,132	31,028,851	Jan 26 04:05 PM
DeSantis Deborah	10% Owner	Jan 26 '24	Sale	43.51	128,114	5,574,316	30,961,199	Jan 26 04:05 PM
Milmoe William H.	10% Owner	Jan 24 '24	Sale	43.96	128,309	5,639,952	31,096,560	Jan 26 04:05 PM
Milmoe William H.	10% Owner	Jan 25 '24	Sale	43.64	128,171	5,593,132	31,028,851	Jan 26 04:05 PM
Milmoe William H.	10% Owner	Jan 26 '24	Sale	43.51	128,114	5,574,316	30,961,199	Jan 26 04:05 PM
DeSantis Dean	10% Owner	Jan 24 '24	Sale	43.96	128,309	5,639,952	31,096,560	Jan 26 04:05 PM
DeSantis Dean	10% Owner	Jan 25 '24	Sale	43.64	128,171	5,593,132	31,028,851	Jan 26 04:05 PM
DeSantis Dean	10% Owner	Jan 26 '24	Sale	43.51	128,114	5,574,316	30,961,199	Jan 26 04:05 PM
Milmoe William H.	10% Owner	Jan 22 '24	Sale	47.49	129,658	6,157,119	31,413,662	Jan 23 04:05 PM
Milmoe William H.	10% Owner	Jan 23 '24	Sale	44.01	128,331	5,647,357	31,345,793	Jan 23 04:05 PM
Milmoe William H.	10% Owner	Jan 19 '24	Sale	33.33	60,462	2,015,198	31,603,782	Jan 23 04:05 PM
DeSantis Deborah	10% Owner	Jan 22 '24	Sale	47.49	129,658	6,157,119	31,413,662	Jan 23 04:05 PM
DeSantis Deborah	10% Owner	Jan 23 '24	Sale	44.01	128,331	5,647,357	31,345,793	Jan 23 04:05 PM
DeSantis Deborah	10% Owner	Jan 19 '24	Sale	33.33	60,462	2,015,198	31,603,782	Jan 23 04:05 PM
DeSantis Dean	10% Owner	Jan 22 '24	Sale	47.49	129,658	6,157,119	31,413,662	Jan 23 04:05 PM
DeSantis Dean	10% Owner	Jan 23 '24	Sale	44.01	128,331	5,647,357	31,345,793	Jan 23 04:05 PM
DeSantis Dean	10% Owner	Jan 19 '24	Sale	33.33	60,462	2,015,198	31,603,782	Jan 23 04:05 PM
Milmoe William H.	10% Owner	Jan 04 '24	Option Exercise	1.24	165,000	205,144	224,745	Jan 09 04:05 PM
Fieldly John	Chief Executive Officer	Jan 03 '24	Sale	56.72	27,334	1,550,384	480,926	Jan 05 08:10 PM
Storey Paul H.	SVP, Operations	Jan 03 '24	Sale	56.72	3,468	196,705	46,065	Jan 05 08:00 PM
Langhans Jarrod	Chief Financial Officer	Jan 03 '24	Sale	56.72	2,401	136,185	82,046	Jan 05 07:59 PM
David Toby	Executive Vice President	Jan 03 '24	Sale	56.72	10,809	613,086	104,292	Jan 05 07:58 PM
Guilfoyle Tony	EVP - North American Sales	Jan 03 '24	Sale	56.72	10,809	613,086	99,339	Jan 05 07:56 PM
Kravitz Hal	Director	Dec 06 '23	Sale	51.64	172,000	8,882,080	216,206	Dec 08 04:08 PM
Guilfoyle Tony	EVP - North American Sales	Dec 05 '23	Sale	53.00	17,332	918,596	110,148	Dec 07 04:49 PM
Fieldly John	Chief Executive Officer	Dec 05 '23	Sale	52.41	286,158	14,997,541	522,102	Dec 07 04:44 PM
Fieldly John	Chief Executive Officer	Dec 06 '23	Sale	52.05	13,842	720,476	508,260	Dec 07 04:44 PM
Guilfoyle Tony	EVP - Domestic Sales	Nov 20 '23	Sale	53.14	10,190	541,497	234,340	Nov 21 05:40 PM
Kravitz Hal	Director	Sep 22 '23	Option Exercise	3.48	110,000	382,800	122,797	Sep 25 05:20 PM

CDXC

Chromadex Corp

CELH

Celsius Holdings Inc

Upgrade your FINVIZ experience